Maxim Pharmaceuticals Ltd.

Act 330 Group Assignment 1 23rd october, 2012

Prepared By Safayeyt amin Md Jamal Hossen Md Moniruzzanman Rubel 0920422030 0930106030 1030733030

Prepared For RKB Section 2 Lecturer Department: School of Business

1. Company Name
- Rectangle Pharmaceuticals Limited

2. Industry
-Pharmaceuticals Industry

3. Company Location
-Plant (Gazipur) -Headquarter (Uttara Sector 3, House 22)

4. Products
The name Rectangle Pharmaceuticals assures you of many things: outstanding product quality, leading-edge technology, advanced new products, and a commitment to serve the medical community.

Our products come in a wide range of dosage forms including tablets, capsules, dry syrup, powder for suspension, cream, ointment, suppositories, metered dose nasal sprays, large volume intravenous fluids, metered dose inhalers etc. ensuring the global standard of quality.

5. Company Background
A) .No. of employees 850 (Plant and Office)

B) .No. of departments and their functions in brief Research and Development: The Research and Development department determines and identifies drug candidates. In R&D department, there are three functional areas. They are discovery research, animal sciences and bioinformatics. Operations: The Operations department produces a saleable amount of a drug. Once a drug has passed the clinical trials, the manufacturing and production department manufacture the final product, along with the packaging and labeling. Also housed under the operations umbrella is the environmental health and safety function, which assesses the environmental impact of a potential product. Quality: There are various rules and safety regulations laid down by the FDA for pharmaceuticals and biotech firms. If found guilty for drug contamination then the FDA may close the manufacturing plant of the firm. The Quality department of the pharmaceutical firm also ensures that the firm is adhering to government regulations. There are different groups which concentrate on functions like assurance, quality control as well as validation. These groups ensure that the drugs manufactured are accurate, and of a reliable standard of quality. Finance and Administration: The Finance and Administration department comprises different functional areas including finance, administration, legal and information systems. Responsibilities include managing activities related to finance management, handling legal relations with employees, investors, creditors as well as government regulators. Marketing The marketing department recognizes potential fresh coalition partners and also handles previous alliances. They are responsible for market research, recognizing potential customers and preparing the promotion and pricing strategy. They also handle the distribution of the finished products. Project Management:

Most of the pharmaceutical companies have a separate project management department. This department is responsible for coordinating the functions of all departments and also ensures smooth and efficient functioning. The Project management department also monitors particular projects.

8. DSE Listing Procedure

Listing: i) The company shall apply to the Dhaka Stock Exchange (the Exchange) with an application fee of Tk. 10,000/= (ten thousand), and shall simultaneously furnish a copy thereof, along with the copies of documents mentioned under sub regulation (ii), to the Securities and Exchange Commission (SEC). ii) The company shall, among others, submit the following documents along with the application:(a) Memorandum of Association and Articles of Association. (b) A brief profile of the company, including brief particulars of existing sponsordirectors of the company. (c) Certificate of Incorporation and Certificate of commencement of business. (d) Audited Financial Statements for the last five years. (e) Members/shareholders list together with their shareholding position. (f) Return of allotment(s) filed with the Registrar of Joint Stock Companies and Firms. (g) Existing material agreements, including deed of mortgage (if any). (h) Status of loan, including information concerning loan default, if any, of the company. (i) VAT and Tax identification numbers. (j) Due diligence certificate from the directors as per format prescribed by the Exchange. (k) No objection certificate from the lending bank (s)/financial institutions of the company, if any, where applicable.

(l) Undertaking in the prescribed form as laid down in the listing regulations of the Exchange to the effect that the company shall comply with the securities laws including requirements of the said listing regulations upon listing with the Exchange. (m)Relevant resolution (s) of the shareholders in the general meeting of the company and the Boards resolution, if so authorized, for the purpose of listing with the Exchange. (n) Credit rating report issued by the credit rating company registered with the commission with minimum investment grade of BBB. (o) Information document as per format prescribed by the Exchange. (p) The shareholders resolution in respect of disposal of shares in accordance with the regulation 5.

Financial policy :
The company will release an income statement , statement of cash flows after 1 year or end of a quarter The company will follow straight line depreciation methods to depreciate its assets The company will Make appropriate investments that maximize future cash flows and facilitate efficient operations. The CEO and CFO is responsible for taking decision about taking loan from the bank The CEO , CFO and the Financial executive can take decisions for further investments and the all cheaques must be signed by the CEO , CFO and Financial executive

The CFO and Financial executive will develop the budget of the company and the CEO will approve. But at first the budget must be checked by the auditor Some common reserve funds are 'rainy day', sinking funds , legal liability, research and development, equipment and software acquisition, building maintenance or acquisition. At the end of every year a financial audit procedure must be performed